Beech Hill Advisors Inc. purchased a new position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 7,227 shares of the healthcare conglomerate's stock, valued at approximately $2,254,000.
A number of other large investors have also recently bought and sold shares of the business. Nabity Jensen Investment Management Inc lifted its holdings in shares of UnitedHealth Group by 0.9% in the 1st quarter. Nabity Jensen Investment Management Inc now owns 2,760 shares of the healthcare conglomerate's stock worth $1,446,000 after purchasing an additional 24 shares during the last quarter. Atlantic Edge Private Wealth Management LLC grew its position in UnitedHealth Group by 8.9% in the 1st quarter. Atlantic Edge Private Wealth Management LLC now owns 305 shares of the healthcare conglomerate's stock worth $160,000 after purchasing an additional 25 shares during the last quarter. HHM Wealth Advisors LLC raised its holdings in shares of UnitedHealth Group by 0.9% during the first quarter. HHM Wealth Advisors LLC now owns 2,947 shares of the healthcare conglomerate's stock valued at $1,544,000 after buying an additional 26 shares during the last quarter. Brogan Financial Inc. grew its holdings in UnitedHealth Group by 3.4% in the 1st quarter. Brogan Financial Inc. now owns 819 shares of the healthcare conglomerate's stock worth $429,000 after buying an additional 27 shares in the last quarter. Finally, West Wealth Group LLC raised its stake in UnitedHealth Group by 3.2% during the 1st quarter. West Wealth Group LLC now owns 882 shares of the healthcare conglomerate's stock valued at $462,000 after acquiring an additional 27 shares in the last quarter. Institutional investors own 87.86% of the company's stock.
UnitedHealth Group Trading Up 2.2%
NYSE UNH opened at $364.31 on Tuesday. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The stock has a market cap of $329.95 billion, a price-to-earnings ratio of 15.78, a PEG ratio of 2.31 and a beta of 0.47. The firm's 50 day moving average price is $331.62 and its two-hundred day moving average price is $341.12.
UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business had revenue of $111.62 billion during the quarter, compared to analysts' expectations of $111.75 billion. During the same period in the prior year, the company posted $6.80 earnings per share. The firm's revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were given a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.4%. UnitedHealth Group's dividend payout ratio is presently 38.30%.
Analysts Set New Price Targets
A number of brokerages recently weighed in on UNH. Sanford C. Bernstein lifted their price objective on shares of UnitedHealth Group from $379.00 to $433.00 and gave the company an "outperform" rating in a research note on Wednesday, October 8th. Zacks Research upgraded shares of UnitedHealth Group from a "strong sell" rating to a "hold" rating in a report on Monday, October 6th. UBS Group reaffirmed a "buy" rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. Morgan Stanley upped their price target on shares of UnitedHealth Group from $325.00 to $395.00 and gave the company an "overweight" rating in a report on Friday, September 12th. Finally, Wells Fargo & Company boosted their target price on shares of UnitedHealth Group from $267.00 to $400.00 and gave the stock an "overweight" rating in a report on Tuesday, October 7th. Eighteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have given a Sell rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $385.13.
Check Out Our Latest Report on UnitedHealth Group
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.